Skip to main content
All lobbying filings

COUNCIL FOR INNOVATION PROMOTION (C4IP)

Lobbying for COUNCIL FOR INNOVATION PROMOTION (C4IP) · A coalition dedicated to promoting strong IP rights that drive innovation.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 expenses · posted Apr 21, 2025

Official filing document

 Bills named in this filing 14
  • S 2220
    Fighting for the Overlooked Recognition of Groups Operating in Toxic Test Environments in Nevada (FORGOTTEN) Veterans A…
  • HR 4370
    SAMS Act of 2025
  • S 2140
    Haskell Indian Nations University Improvement Act
  • S 2934
    Protecting Americans from Russian Litigation Act of 2025
  • HR 8684
    Transparency in Billing Act of 2026
  • HR 9221
    Outdoor Americans with Disabilities Act
  • S 4713
    Preventing Payouts for Insurrectionists Act
  • S 2780
    No Tax on Large Party Tips Act
  • S 527
    Prescription Pricing for the People Act of 2025
  • HR 9474
    Patent Eligibility Restoration Act of 2024
  • S 1040
    Drug Competition Enhancement Act
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
  • S 4840
    RESTORE Patent Rights Act of 2024
 Lobbying activity 2
Copyright/Patent/Trademark

General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.4713 - The IDEA Act S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies H.R. 9474 Patent Restoration Act (PERA) of 2024 S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025

Trade (domestic/foreign)

General advocacy in support of pro-IP/innovation policies ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem